Latest Clinical & Research News
A multicenter quality improvement study, IMPLEMENT-HF, shows that a centralized virtual team make suggestions to treating clinicians about caring for hospitalized patients with HFrEF improved the use of guideline-concordant medical therapy.
Read More...
In a proof-of-concept study, Stella E. Lee, MD, director of the Sinus Center in the Division of Otolaryngology–Head & Neck Surgery at Brigham and Women’s Hospital, and colleagues demonstrated a safe, portable, objective method for measuring smell function and its relationship with cognitive processing.
Read More...
Farhad R. Nezami, PhD, lead investigator in the Division of Cardiac Surgery at Brigham and Women’s Hospital, is a mechanical and aerospace engineer by training. His lab pulls from engineering, computer science, and bioinformatics to uncover better diagnostic tools and predictors of clinical events.
Read More...
Physicians at Brigham and Women’s Hospital recently encountered a patient with exertional dyspnea and inducible laryngeal obstruction at rest who was ultimately diagnosed with hypertrophic cardiomyopathy as the cause of his symptoms.
Read More...
In an observational study in “real-world” practice, Brigham and Women’s Hospital researchers did not identify significant differences in antibody response to COVID-19 vaccination among rheumatoid arthritis patients who held versus continued disease-modifying anti-rheumatic drugs for the last dose of the primary series.
Read More...
After decades as a practicing surgeon, Pardon R. Kenney, MD, MS, was ready to step away from the operating room—but not from medicine or his love of teaching. In the Brigham’s new Section of Surgical Educators, he now shares the knowledge he has amassed with new medical students, residents, and attending physicians.
Read More...
Tammy T. Hshieh, MD, MPH, and colleagues recently explored from a healthcare system perspective the direct costs of delirium in hospitalized patients with and without Alzheimer’s disease or a related disorder.
Read More...
Michael E. Weinblatt, MD, and colleagues are conducting the first randomized, placebo-controlled study using an immunomodulator with pegloticase to increase urate-lowering response durability. Initial findings confirm the superiority of pegloticase plus methotrexate co-therapy to pegloticase monotherapy.
Read More...
Christopher D. Dwyer, MD, Thomas L. Carroll, MD, and colleagues present the first publication to describe the use of Silk–HA (Silk Voice) for augmenting vocal fold tissue for phonation improvement in patients, including clinical pearls and suggestions for the informed consent process.
Read More...
Researchers at Brigham and Women’s Hospital recently reported that somatic variants—specifically, in the supervillin (SVIL) gene—increase susceptibility to intracranial aneurysms through changes in vascular smooth muscle cells (vSMCs).
Read More...